28 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

• SINTX Technologies, Inc. (NASDAQ:SINT) shares increased by 38.0% to $2.07 during Thursday's pre-market session. The market cap seems to be at $6.5 million.
• Valeritas Holdings, Inc. (NASDAQ:VLRX) shares rose 19.9% to $2.23. The market cap seems to be at $69.7 million.
• Ardelyx, Inc. (NASDAQ:ARDX) shares moved upwards by 10.3% to $6.40. The market cap stands at $255.5 million.
• Jaguar Health, Inc. (NASDAQ:JAGX) stock moved upwards by 9.1% to $1.20. The market value of their outstanding shares is at $9.3 million.
• vTv Therapeutics, Inc. (NASDAQ:VTVT) stock rose 8.8% to $1.60.
• Moderna, Inc. (NASDAQ:MRNA) shares rose 5.2% to $16.75.
• Precipio, Inc. (NASDAQ:PRPO) stock increased by 3.7% to $2.55.
• Obalon Therapeutics, Inc. (NASDAQ:OBLN) shares rose 3.0% to $2.20. The market cap seems to be at $42.3 million.
• InMode, Inc. (NASDAQ:INMD) shares moved upwards by 2.7% to $27.56.
• CannTrust Holdings, Inc. (NYSE:CTST) stock increased by 2.4% to $1.70. The market value of their outstanding shares is at $555.7 million.
• T2 Biosystems, Inc. (NASDAQ:TTOO) stock increased by 2.3% to $2.67. The market value of their outstanding shares is at $209.3 million. According to the most recent rating by Janney Capital, on September 12, the current rating is at Buy.
• Aimmune Therapeutics, Inc. (NASDAQ:AIMT) shares surged 2.1% to $26.00. The market value of their outstanding shares is at $1.9 billion.

Losers

• Tocagen, Inc. (NASDAQ:TOCA) stock plummeted 82.1% to $0.75 during Thursday's pre-market session. The market cap stands at $219.2 million.
• Adverum Biotechnologies, Inc. (NASDAQ:ADVM) shares declined 45.2% to $6.58.
• Histogenics, Inc. (NASDAQ:HSGX) shares decreased by 14.0% to $0.21. The market cap stands at $52.8 million.
• Celyad, Inc. (NASDAQ:CYAD) shares declined 13.2% to $10.69. The market cap stands at $422.7 million.
• Aurora Cannabis, Inc. (NYSE:ACB) stock declined 9.9% to $5.83. The market value of their outstanding shares is at $6.3 billion. According to the most recent rating by Bank of America, on July 18, the current rating is at Neutral.
• Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) stock decreased by 8.9% to $6.77. The market cap stands at $46.1 million.
• Aphria, Inc. (NYSE:APHA) stock plummeted 4.5% to $6.58. According to the most recent rating by CIBC, on July 26, the current rating is at Underperformer.
• Motif Bio, Inc. (NASDAQ:MTFB) stock declined 3.9% to $0.67. The market cap seems to be at $11.5 million.
• AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) shares fell 3.1% to $0.95. The market cap seems to be at $571.7 million. The most recent rating by H.C. Wainwright, on September 11, is at Buy, with a price target of $1.75.
• Mallinckrodt, Inc. (NYSE:MNK) shares declined 3.0% to $3.25. The most recent rating by Stifel, on September 09, is at Hold, with a price target of $8.00.
• Canopy Growth, Inc. (NYSE:CGC) stock declined 3.0% to $26.60. The most recent rating by Seaport Global, on August 26, is at Buy, with a price target of $31.00.
• Xenetic Biosciences, Inc. (NASDAQ:XBIO) stock decreased by 2.6% to $1.51.
• Cronos Group, Inc. (NASDAQ:CRON) shares plummeted 2.5% to $11.25. The most recent rating by Piper Jaffray, on August 13, is at Overweight, with a price target of $18.00.
• Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stock fell 2.3% to $2.15. The market value of their outstanding shares is at $1.1 billion. According to the most recent rating by Gabelli & Co., on September 11, the current rating is at Buy.
• Fate Therapeutics, Inc. (NASDAQ:FATE) shares plummeted 2.1% to $18.00. The market cap stands at $185.1 million. The most recent rating by BTIG, on August 09, is at Buy, with a price target of $27.00.
• Tilray, Inc. (NASDAQ:TLRY) stock declined 2.0% to $30.10. According to the most recent rating by Ladenburg Thalmann, on July 17, the current rating is at Neutral.